0R9G Stock Overview
Operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Naturhouse Health, S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.69 |
52 Week High | €2.21 |
52 Week Low | €1.56 |
Beta | 0.76 |
11 Month Change | 0.90% |
3 Month Change | -19.14% |
1 Year Change | 4.97% |
33 Year Change | -8.65% |
5 Year Change | n/a |
Change since IPO | -64.12% |
Recent News & Updates
Recent updates
Shareholder Returns
0R9G | GB Specialty Retail | GB Market | |
---|---|---|---|
7D | -0.6% | -3.7% | 1.7% |
1Y | 5.0% | -7.6% | 8.3% |
Return vs Industry: 0R9G exceeded the UK Specialty Retail industry which returned -7.3% over the past year.
Return vs Market: 0R9G underperformed the UK Market which returned 8% over the past year.
Price Volatility
0R9G volatility | |
---|---|
0R9G Average Weekly Movement | 4.8% |
Specialty Retail Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0R9G has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0R9G's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 197 | Felix Fernandez | www.naturhouse.com |
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products.
Naturhouse Health, S.A. Fundamentals Summary
0R9G fundamental statistics | |
---|---|
Market cap | €101.61m |
Earnings (TTM) | €9.74m |
Revenue (TTM) | €49.90m |
10.4x
P/E Ratio2.0x
P/S RatioIs 0R9G overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0R9G income statement (TTM) | |
---|---|
Revenue | €49.90m |
Cost of Revenue | €14.18m |
Gross Profit | €35.72m |
Other Expenses | €25.97m |
Earnings | €9.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.16 |
Gross Margin | 71.58% |
Net Profit Margin | 19.53% |
Debt/Equity Ratio | 4.6% |
How did 0R9G perform over the long term?
See historical performance and comparison